<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">
Log In

SmartTRAK Life Sciences News and Analysis Blog

1 min read

Tissue Regenix Cites BioMedGPS SmartTRAK as Source

7/17/17 8:00 AM

Tissue Regenix.jpgTissue Regenix cited BioMedGPS SmartTRAK as a source when compiling their Corporate Overview for presentation at the Jeffries Healthcare Conference.

Tissue Regenix, founded in 2006 as a spin out of Leeds University in the UK, was established to commercialize academic research in regenerative medicine. Utilizing its unique dCell technology the Company develops and commercializes biocompatible acellular scaffolds derived from xenogenic and allogenic sources for wound care, orthopedic surgery and cardiovascular applications.

Subscribe Now for SmartTRAK Blog News Email

Topics: SmartTRAK News

Susan Paquette
Written by Susan Paquette

Susan Paquette, MS, MBA | Vice President and General Manager, Wound. 25+ years' experience in new business development, R&D, international and marketing. Director, New Business Development & Commercialization, 3M Health Care; Technical Director, 3M Medical.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles

Innovation On Display at the 2nd Annual AAOS OrthoPitch

SmartTRAK highlights AAOS’ OrthoPitch 2025 finalists. Innovation has always been a key growth...Read more

Joint Restoration and Preservation: The CG MSK & AAOS 2025 Playbill

Soft tissue and cartilage repair trends and innovations take center stage. Joint restoration and...Read more

The Impact of Data in Medtech: Alpha Sophia Interviews SmartTRAK's Joe Mish

Recently, SmartTRAK's VP of Sales, Joe Mish, sat down with the Alpha Sophia podcast to discuss the...Read more